NRXP   $0.425  -1.87% Market Closed

NRX Pharmaceuticals Inc
Total Cash 8.90M
totalCashPerShare 0.107
EBITDA -33.06M
Total Debt 10.07M
quickRatio 0.461
currentRatio 0.677
Total Revenue
debtToEquity
Revenue/Share
ROA -1.08969
ROE -6.82612
grossProfits
freeCashflow -14.75M
operatingCashflow -26.78M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 45.29M
forwardPE -1.815
floatShares 57.55M
sharesOutstanding 92.43M
sharesShort 3.71M
sharesShortPriorMonth 3.87M
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.31%
heldPercentInstitutions 0.04%
Short Ratio help_outline 1.31%
shortPercentOfFloat 0.06%
impliedSharesOutstanding
bookValue -0.075
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -36.06M
trailingEps -0.50%
forwardEps -0.26%
enterpriseToEbitda -1.37
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.07 4Q 2023
institutionsCount 38
lastUpdated April 1, 2024, 3:10 p.m.